Answers are grounded in this paper and cite their sources.
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a wide range of clinical manifestations and a relapsing-remitting course. New data regarding pathogenic pathways, biomarkers and clinical manifestations of SLE are emerging, and new drugs and therapeutic protocols have been proposed to improve the control of disease activity. Furthermore, new insights into comorbidities and reproductive health in SLE patients are constantly emerging.This annual review aims to summarise the most relevant data on SLE that was published in 2022.
No takes yet. Share an insight, caveat, or question.
Zucchi et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: